Abbott Labs, Quest Diagnostics ink $60 million supply agreement

<%=company1%> (Abbott Park, IL) and Quest Diagnostics Inc. (Teterboro, NJ) have signed a two-year, $60 million supply agreement, under which Abbott will provide Quest Diagnostics with immunoassay tests and systems for hepatitis, cancer, cardiac conditions, and therapeutic drug monitoring.

The agreement also allows Quest to use Abbott's PSA (prostate-specific antigen) and homocysteine assays. The PSA assay is a blood test for early detection of prostate cancer; the homocysteine test is an automated test that measures levels of homocysteine, an amino acid, identified as a risk factor for cardiovascular disease.

Quest Diagnostics is a provider of diagnostic testing, information, and services.

Abbott Laboratories is a global, diversified health care company that discovers, develops, manufactures, and markets pharmaceutical, diagnostic, nutritional, and hospital products.

For more information: Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064-6400. Tel: 847-937-6100. Fax: 847-937-1511.

Edited by Jim Pomager
Assistant Editor, Pharmaceutical Online